DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Garenoxacin
Garenoxacin
The Role of Nanobiosensors in Therapeutic Drug Monitoring
List Item Withdrawal Assessment Report for Garenoxacin Mesylate
Powerpoint 簡報
And Levofloxacin Against Intracellular Staphylococcus Aureus Or Listeria Monocytogenes in J774 Macrophages
WHO Report on Surveillance of Antibiotic Consumption: 2016-2018 Early Implementation ISBN 978-92-4-151488-0 © World Health Organization 2018 Some Rights Reserved
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
The Role of the Immune Response in the Effectiveness of Antibiotic Treatment for Antibiotic Susceptible and Antibiotic Resistant Bacteria
Surveillance of Antimicrobial Consumption in Europe 2013-2014 SURVEILLANCE REPORT
S. Pneumoniae Including Tentative Susceptibility Testing Criteria E-58 RN Jones, a Mutnick, and D Biedenbach
A Case of Anaphylaxis Following Administration of Garenoxacin
Antibiotics and Urinary Tract Infections
Geninax Tablets 200 Mg [Non-Proprietary Name] Garenoxacin Mesilate Hydrate (JAN*) [Applicant] Toyama Chemical Co., Ltd
Studies on Salmonella Typhimurium DNA Gyrase and the Impact of Gyra Mutations to Quinolone Susceptibility [An Title Abstract of Entire Text]
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Antibiotic-Loaded Polymeric Microspheres for Passive Lung Targeting After Intravenous Administration
Muhammad Zahid
Classification of Anti‐Bacterial Agents and Their Functions
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
Top View
Quinolone Antibiotics
Introduction and Geographic Availability of New Antibiotics Approved Between 1999 and 2014
Chapter 2A Fluoroquinolones for Tuberculosis: a PK/PD Approach
New Perspectives on Antibacterial Drug Research
I C a a C 2 0
S. Pneumoniae, H. Influenzae
Review of Properties and Analytical Methods for the Determination of Norfloxacin
A ABSSSI. See Acute Bacterial Skin and Skin Structure Infections
Inhibitors of Nucleic Acid Synthesis the Antibacterial Drugs That Inhibit
Quinolines-Based SARS-Cov-2 3Clpro and Rdrp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: an in Silico Analysis
Association Between Third-Generation Fluoroquinolones and Achilles Tendon Rupture: a Self-Controlled Case Series Analysis
Targeting Innovation in Antibiotic Drug Discovery and Development (2016)
SUMMARY NIAID Workshop 'Pharmacokinetics-Pharmacodynamics (PKPD) for Development of Therapeutics Against Bacterial Pathogens J
Antibiotics in the Clinical Pipeline in 2011
P1002 Paper Poster Session V Assaying and Explaining Multidrug
New ATC Codes and New Ddds to Be Included in the 2019 Edition of the ATC/DDD Index Are Also Enclosed
Update to the European Union Guideline on Antibacterial Agents
Doctoral Thesis Absorption, Safety and Tolerability of a Topical Quinolone
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter Pylori: a Literature Review
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Anti-Leprosy Drugs: Modes of Action and Mechanisms of Resistance in Mycobacterium Leprae
Critically Important Antimicrobials for Human Medicine, 6Th Revision
Comparative Articular Toxicity of Garenoxacin, a Novel Quinolone Antimicrobial Agent, in Juvenile Beagle Dogs
Microorganisms
Antimicrobial Medicines Consumption in Eastern Europe and Central Asia – an Updated Cross-National Study and Assessment of Quantitative Metrics for Policy Action
QVA149 / Indacaterol / Glycopyrronium Bromide
Critically Important Antimicrobials for Human Medicine
LC–MS Based Assay to Measure Intracellular Compound Levels in Mycobacterium Smegmatis: Linking Compound Levels to Cellular Potency☆
Evaluation of Various Quinolone Antimicrobial Disks to Screen for Fluoroquinolone Resistance in Salmonella Spp
Summary of Investigation Results Fluoroquinolones and Quinolones (Oral and Injectable Dosage Forms)
(12) Patent Application Publication (10) Pub. No.: US 2017/0071884 A1 Page Et Al
Antibiotics in the Clinical Pipeline in 2013
Antibiotic Use and Resistance in Food Animals Current Policy and Recommendations © Center for Disease Dynamics, Economics & Policy, 2016
Surveillance of Antimicrobial Consumption in Europe 2012 Surveillance of Antimicrobial Consumption in Europe 2012
A Case Study Report
Second-Line Antituberculosis Drugs in Children